Sri Padmam Biosciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.55 Cr
- Revenue Growth -29.97%
- Profit Growth -692.25%
- Ebitda -465.86%
- Net Worth -63.26%
- Total Assets -33.64%
About Sri Padmam Biosciences
Sri Padmam Biosciences Private Limited (SPBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 May 2006 and has a history of 18 years and nine months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.55 Cr.
Thiruvenkatachari Ramachandran and Thiruvenkatachari Narasimhan serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231TN2006PTC059677
-
Company No.
059677
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 May 2006
-
Date of AGM
28 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Sri Padmam Biosciences Private Limited offer?
Sri Padmam Biosciences Private Limited offers a wide range of products and services, including Immunization & Vaccination Drugs, Infant Vaccines, Vaccines, Common Disease Medicines, Injectable Products, Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections.
Who are the key members and board of directors at Sri Padmam Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thiruvenkatachari Ramachandran
|
Director | 11-May-2006 | Current |
|
Thiruvenkatachari Narasimhan
|
Director | 11-May-2006 | Current |
Financial Performance of Sri Padmam Biosciences.
Sri Padmam Biosciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 29.97% decrease. The company also saw a substantial fall in profitability, with a 692.25% decrease in profit. The company's net worth observed a substantial decline by a decrease of 63.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Padmam Biosciences?
In 2023, Sri Padmam Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹15.48 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.50 Cr
- City Union Bank Limited : 0.04 Cr
- City Union Bank : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Apr 2010 | City Union Bank | ₹0.08 M | Open |
| 30 Jun 2009 | City Union Bank Limited | ₹0.40 M | Open |
| 21 Jun 2007 | Others | ₹1.50 Cr | Open |
How Many Employees Work at Sri Padmam Biosciences?
Unlock and access historical data on people associated with Sri Padmam Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Padmam Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Padmam Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.